Serum estradiol level change after human chorionic gonadotropin administration had no correlation with live birth rate in IVF cycles

Rui Huang; Cong Fang; Ningning Wang; Lilin Li; Yanhong Yi; Xiaoyan Liang

doi:10.1016/j.ejogrb.2014.02.040

Serum estradiol level change after human chorionic gonadotropin administration had no correlation with live birth rate in IVF cycles

Eur J Obstet Gynecol Reprod Biol. 2014 Jul:178:177-82. doi: 10.1016/j.ejogrb.2014.02.040. Epub 2014 Mar 12.

Authors

Rui Huang¹, Cong Fang², Ningning Wang³, Lilin Li², Yanhong Yi⁴, Xiaoyan Liang²

Affiliations

¹ Reproductive Medicine Center, Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, PR China; Reproductive Medicine Center, Women and Children Hospital of Guangdong Province, Guangzhou, PR China. Electronic address: drhuangr@hotmail.com.
² Reproductive Medicine Center, Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, PR China.
³ Department of Statistics, Guangzhou Medical College, Guangzhou, PR China.
⁴ Reproductive Medicine Center, Women and Children Hospital of Guangdong Province, Guangzhou, PR China.

PMID: 24862918
DOI: 10.1016/j.ejogrb.2014.02.040

Abstract

Objective: To investigate the correlation between the estradiol (E2) level change after hCG administration and the live birth rate in GnRH agonist long or short protocols, and to explore the possible factors related to E2 dynamics after hCG administration during controlled ovarian hyperstimulation (COH).

Study design: A retrospective analysis was performed on 2868 patients who received IVF/intracytoplasmic sperm injection (ICSI) treatment with GnRH agonist long or short protocol. The patients were divided into three groups according to their serum E2 changes after hCG administration, and the live birth rates were compared among groups. The area under the receiver operating characteristic (ROC) curve was calculated to assess the predictive value of E2 change for the probability of live birth. Logistic regression analysis was also applied to exclude interference from various confounding factors. Finally, multivariate regression analysis was conducted to assess factors related to the E2 change after hCG administration.

Results: No significant difference was observed in live birth rates (4.26%, 36.38% or 30.81% in long protocol (P=0.697); 25.81%, 26.71% or 30.81% in short protocol (P=0.697)) among patients with increasing, plateauing or decreasing E2 responses after hCG administration. The area under the ROC curve for the E2 change in prediction of live birth rate was 0.506 in long protocol, or 0.524 in short protocol. Logistic regression analysis showed that the serum E2 change after hCG administration had no correlation with live birth rate. Multivariate regression analysis showed that the percentage of mature follicles (larger than 14mm) and the duration of stimulation negatively correlated with the E2 change after hCG administration.

Conclusions: In GnRH agonist cycles, the serum E2 change after hCG administration had no correlation with live birth rate in fresh embryo transfer cycles, and this change negatively correlated with the percentage of mature follicles on the day of hCG administration.

Keywords: Estradiol; GnRH agonist; In vitro fertilization; Live birth rate.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Birth Rate*
Chorionic Gonadotropin / administration & dosage
Chorionic Gonadotropin / agonists*
Estradiol / blood*
Female
Fertilization in Vitro / methods
Humans
Ovulation Induction / methods
Pregnancy
Retrospective Studies
Sperm Injections, Intracytoplasmic

Substances

Chorionic Gonadotropin
Estradiol